Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter W. Hellings; Anju T. Peters; Adam M. Chaker; Enrico Heffler; Haixin Zhang; Amy Praestgaard; Scott Nash; Asif H. Khan; Shahid Siddiqui; Juby A. Jacob-Nara; Paul J. Rowe; Yamo Deniz

doi:10.1002/alr.22944

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter W. Hellings^*, Anju T. Peters, Adam M. Chaker, Enrico Heffler, Haixin Zhang, Amy Praestgaard, Scott Nash, Asif H. Khan, Shahid Siddiqui, Juby A. Jacob-Nara, Paul J. Rowe, Yamo Deniz

^*Corresponding author for this work

Medicine, Allergy Division

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	958-962
Number of pages	5
Journal	International Forum of Allergy and Rhinology
Volume	12
Issue number	7
DOIs	https://doi.org/10.1002/alr.22944
State	Published - Jul 2022

Funding

Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02912468 (SINUS‐24) and NCT02898454 (SINUS‐52). informationResearch sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02912468 (SINUS-24) and NCT02898454 (SINUS-52).We thank Matt Lewis, PhD, of Adelphi Group, Macclesfield, UK, for medical writing/editorial assistance funded by Sanofi-Genzyme and Regeneron Pharmaceuticals, Inc., in accordance with Good Publications Practice (GPP3) guidelines.

Keywords

medical therapy of chronic rhinosinusitis
olfaction
quality of life

ASJC Scopus subject areas

Immunology and Allergy
Otorhinolaryngology

Access to Document

10.1002/alr.22944

Cite this

@article{035a029d77ae4bd48add0a00402e0efa,

title = "Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps",

keywords = "medical therapy of chronic rhinosinusitis, olfaction, quality of life",

author = "Hellings, {Peter W.} and Peters, {Anju T.} and Chaker, {Adam M.} and Enrico Heffler and Haixin Zhang and Amy Praestgaard and Scott Nash and Khan, {Asif H.} and Shahid Siddiqui and Jacob-Nara, {Juby A.} and Rowe, {Paul J.} and Yamo Deniz",

note = "Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02912468 (SINUS‐24) and NCT02898454 (SINUS‐52). Funding Information: informationResearch sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02912468 (SINUS-24) and NCT02898454 (SINUS-52).We thank Matt Lewis, PhD, of Adelphi Group, Macclesfield, UK, for medical writing/editorial assistance funded by Sanofi-Genzyme and Regeneron Pharmaceuticals, Inc., in accordance with Good Publications Practice (GPP3) guidelines.",

year = "2022",

month = jul,

doi = "10.1002/alr.22944",

language = "English (US)",

volume = "12",

pages = "958--962",

journal = "International Forum of Allergy and Rhinology",

issn = "2042-6976",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

AU - Hellings, Peter W.

AU - Peters, Anju T.

AU - Chaker, Adam M.

AU - Heffler, Enrico

AU - Zhang, Haixin

AU - Praestgaard, Amy

AU - Nash, Scott

AU - Khan, Asif H.

AU - Siddiqui, Shahid

AU - Jacob-Nara, Juby A.

AU - Rowe, Paul J.

AU - Deniz, Yamo

N1 - Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02912468 (SINUS‐24) and NCT02898454 (SINUS‐52). Funding Information: informationResearch sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02912468 (SINUS-24) and NCT02898454 (SINUS-52).We thank Matt Lewis, PhD, of Adelphi Group, Macclesfield, UK, for medical writing/editorial assistance funded by Sanofi-Genzyme and Regeneron Pharmaceuticals, Inc., in accordance with Good Publications Practice (GPP3) guidelines.

PY - 2022/7

Y1 - 2022/7

KW - medical therapy of chronic rhinosinusitis

KW - olfaction

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85123503731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123503731&partnerID=8YFLogxK

U2 - 10.1002/alr.22944

DO - 10.1002/alr.22944

M3 - Article

C2 - 34911163

AN - SCOPUS:85123503731

SN - 2042-6976

VL - 12

SP - 958

EP - 962

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

IS - 7

ER -

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this